Literature DB >> 2556498

Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.

G Lennox1, J Lowe, M Landon, E J Byrne, R J Mayer, R B Godwin-Austen.   

Abstract

Diffuse Lewy body disease is an important pathological substrate of the common syndrome of parkinsonian dementia. The new technique of anti-ubiquitin immunocytochemistry has been used in a correlative quantitative neuropathological study of fifteen cases of diffuse Lewy body disease, showing that the severity of dementia is related to cortical Lewy body density, whilst subcortical abnormalities make a much less significant contribution. Cortical senile plaques also appear to be part of the pathology of diffuse Lewy body disease and should not therefore be used as an isolated diagnostic criterion for Alzheimer's disease. Diagnostic criteria for diffuse Lewy body disease are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556498      PMCID: PMC1031631          DOI: 10.1136/jnnp.52.11.1236

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  53 in total

1.  Clinically and neuropathologically distinct form of dementia in the elderly.

Authors:  R H Perry; D Irving; G Blessed; E K Perry; A F Fairbairn
Journal:  Lancet       Date:  1989-01-21       Impact factor: 79.321

2.  Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.

Authors:  P J Whitehouse
Journal:  Adv Neurol       Date:  1987

3.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

4.  Primary degenerative dementia without Alzheimer pathology.

Authors:  A W Clark; C L White; H J Manz; I M Parhad; B Curry; P J Whitehouse; J Lehmann; J T Coyle
Journal:  Can J Neurol Sci       Date:  1986-11       Impact factor: 2.104

5.  The Global Deterioration Scale for assessment of primary degenerative dementia.

Authors:  B Reisberg; S H Ferris; M J de Leon; T Crook
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

6.  Pathological basis for neurotransmitter changes in Parkinson's disease.

Authors:  D M Mann; P O Yates
Journal:  Neuropathol Appl Neurobiol       Date:  1983 Jan-Feb       Impact factor: 8.090

7.  How common is dementia in Parkinson's disease?

Authors:  R G Brown; C D Marsden
Journal:  Lancet       Date:  1984-12-01       Impact factor: 79.321

8.  Neuropathological definition of Alzheimer disease: multivariate analyses in the morphometric distinction between Alzheimer dementia and normal aging.

Authors:  M J Ball; S Griffin-Brooks; J A MacGregor; B Nagy; E Ojalvo-Rose; P H Fewster
Journal:  Alzheimer Dis Assoc Disord       Date:  1988       Impact factor: 2.703

9.  Alzheimer's disease with widespread presence of Lewy bodies.

Authors:  Y Mitsuyama; H Fukunaga; M Yamashita
Journal:  Folia Psychiatr Neurol Jpn       Date:  1984

10.  Pathologic correlates of dementia in Parkinson's disease.

Authors:  H C Chui; J A Mortimer; U Slager; C Zarow; W Bondareff; D D Webster
Journal:  Arch Neurol       Date:  1986-10
View more
  26 in total

1.  Familial encephalopathy with neuroserpin inclusion bodies.

Authors:  R L Davis; P D Holohan; A E Shrimpton; A H Tatum; J Daucher; G H Collins; R Todd; C Bradshaw; P Kent; D Feiglin; A Rosenbaum; M S Yerby; C M Shaw; F Lacbawan; D A Lawrence
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer.

Authors:  Bruno Fauvet; Martial K Mbefo; Mohamed-Bilal Fares; Carole Desobry; Sarah Michael; Mustafa T Ardah; Elpida Tsika; Philippe Coune; Michel Prudent; Niels Lion; David Eliezer; Darren J Moore; Bernard Schneider; Patrick Aebischer; Omar M El-Agnaf; Eliezer Masliah; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

Review 3.  Medicine in the elderly.

Authors:  P Diggory; A Homer; J Liddle; C F Pratt; S Samadian; R Tozer; C Weinstein
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

4.  Behavioural disturbance and visual hallucinations in a 78 year old man.

Authors:  D W Schultz; G G Lennox; J W Ironside; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

5.  Dementia with lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography.

Authors:  Z Walker; D C Costa; A G Janssen; R W Walker; G Livingstone; C L Katona
Journal:  Eur J Nucl Med       Date:  1997-06

Review 6.  Diffuse Lewy body disease in Japan.

Authors:  K Kosaka
Journal:  J Neurol       Date:  1990-06       Impact factor: 4.849

Review 7.  Antipsychotic medications and the elderly: effects on cognition and implications for use.

Authors:  M J Byerly; M T Weber; D L Brooks; L R Snow; M A Worley; E Lescouflair
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 8.  Is synaptic loss a unique hallmark of Alzheimer's disease?

Authors:  Stephen W Scheff; Janna H Neltner; Peter T Nelson
Journal:  Biochem Pharmacol       Date:  2014-01-09       Impact factor: 5.858

Review 9.  Molecular mechanisms of alpha-synuclein neurodegeneration.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  Biochim Biophys Acta       Date:  2008-10-09

10.  Neuroleptic sensitivity in patients with senile dementia of Lewy body type.

Authors:  I McKeith; A Fairbairn; R Perry; P Thompson; E Perry
Journal:  BMJ       Date:  1992-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.